Searching:
Search by keyword, patent number, inventor, assignee, city or state:
| Patent # | Description |
|---|---|
| US-5,574,046 |
Heteroaryl amines as novel acetylcholinesterase inhibitors Compounds of the formula ##STR1## wherein ring A, ring B, ring D, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, R.sup.11, R.sup.12, R.sup.13, E, G, X and P... |
| US-5,574,045 |
Oral pharmaceutical composition of piperidinoalkanol compounds in
solution form The present invention provides an oral pharmaceutical composition in solution form, comprising, a) a therapeutically effective amount of a piperidinoalkanol compound... |
| US-5,574,044 |
Muscarine antagonists Compounds, 1,3-dihydro-1-{1-[piperidin-4-yl]piperidin-4-yl}-2H-benzimidazol-2-ones and 1,3-dihydro-1-{4-amino-1-cyclohexyl}-2H-benzimidazol-2-ones and ... |
| US-5,574,043 |
Certain [1,2,5-thiadiazol-4-yl]-1-azabicyclo [3.2.1]octane derivatives
and their pharmaceutical uses The present invention relates to therapeutically active azabicyclic compounds, a method of preparing the same and to pharmaceutical compositions comprising the... |
| US-5,574,042 |
Imidazo [1,2-a] pyridines and their pharmaceutical use The invention relates to novel bradykinin antagonists of the formula: ##STR1## wherein R.sup.1 is halogen, R.sup.2 and R.sup.3 are each hydrogen, lower alkyl,... |
| US-5,574,041 |
Use of spiperone derivatives as immunosuppressant agents A method for suppressing an immune response in a mammal by treating the mammal with an effective amount of spiperone derivative that is without significant... |
| US-5,574,040 |
Pyrimidine compounds and methods of use to derivatize neighboring lysine
residues in proteins under physiologic... A compound according to the formula: ##STR1## wherein A=CH.sub.3 or CH.sub.2 CH.sub.3 and ##STR2## wherein X=NH.sub.2, CH.sub.2 or CH.sub.2 CH.sub.3 ;... |
| US-5,574,039 |
Antiproliferative compounds having nitrogen-containing tricyclic ring
systems and phenyl substituents The invention relates to TS-inhibiting compounds of the formula ##STR1## where W is an alkylene group; D is a structure having two rings that are ... |
| US-5,574,038 |
5,6-cyclicimidazo [1,5-a] Quinoxalines The invention discloses imidazo[1,5-a]quinoxalines (I) ##STR1## which do not contain an endocyclic carbonyl group that are useful as anxiolytic and... |
| US-5,574,037 |
Amino 1,3,5-triazine derivatives as agents for cardiovascular system This invention concerns novel compounds of the formula I: ##STR1## in which P is a group of formula II or a group of formula III; R.sup.1 is alkyl,... |
| US-5,574,036 |
Adamantyl-substituted polycyclic acetylene compounds and
pharmaceutical/cosmetic compositions comprised thereof Novel pharmaceutically/cosmetically-active adamantyl-substituted polycyclic acetylene compounds have the structural formula (I): ##STR1## wherein Ar is a... |
| US-5,574,035 |
S-timolol hemihydrate composition and method of preparation therefor A novel compound and method for making and using compositions containing S--(--)-3-morpholino-4-(3-tert-butylamino-2-hydroxypropoxy)-1,2,5 thiadiazole... |
| US-5,574,034 |
Pyrrolyl naphthopyrans The invention provides pharmaceutical compounds of the formula: ##STR1## in which A - - - B is CH.sub.2 --CH.sub.2 or CH.dbd.CH; X is a pyridine or benzene... |
| US-5,574,033 |
Heterocyclic compound and cardiotonic agent containing the same as
effective component Heterocyclic compounds of the formula: ##STR1## and a cardiotonic agent containing the same which have an excellent positive inotropic effect and which... |
| US-5,574,032 |
N-[(4-(he
teroaryl)-1-piperazinyl)alkyl]-10,11-dihydro-5H-dibenz[BFS]azepines and
related compounds and... Heteroarylpiperidines, pyrrolidines, and piperazines are useful as antipsychotic and analgesic agents, the compounds are especially useful for treating psychoses... |
| US-5,574,031 |
Piperazine carboxamides Compounds of general formula (I) are useful for treating mental disorders, wherein R.sub.1 and R.sub.2 are the same or different and selected from hydrogen or... |
| US-5,574,030 |
N-aminoalkyl-substituted nitrogen-containing five membered heterocyclic
compounds Disclosed are new alkylenediamine derivatives of the following formula which are effective for treatment of dysuria are disclosed: ##STR1## wherein R.sup.1... |
| US-5,574,029 |
Method for treating anxiety The present invention provides a method for treating anxiety in a human in need thereof, comprising administering an antianxiety amount of a muscarinic agonist... |
| US-5,574,028 |
Method for treating anxiety The present invention provides a method for treating anxiety in a human in need thereof, comprising administering to the human an antianxiety amount of a... |
| US-5,574,027 |
Pharmaceutical compositions of gallium complexes of 3-hydroxy-4-pyrones Disclosed are pharmaceutical compositions that comprise gallium complexes of 3-hydroxy-4-pyrones. These compositions provide enhanced gallium bioavailability... |
| US-5,574,026 |
Methods for inhibiting angiogenesis proliferation of endothelial or
tumor cells and tumor growth The invention relates to a method for inhibiting angiogenesis and proliferation of endothelial cells by administering an inhibitory amount of a... |
| US-5,574,025 |
Inhibitors of prenyl-protein transferases The compounds disclosed inhibit the prenylation of several proteins. These compounds are potent inhibitors of famesyl-protein transferase and ... |
| US-5,574,024 |
Methylene phosphonoalkylphosphinates, pharmaceutical compositions, and
methods for treating abnormal calcium... The present invention involves novel methylene phosphonoalkylphosphinic acids, pharmaceutical compositions containing such compounds, and methods for treating or... |
| US-5,574,023 |
Intramolecularly crosslinked (1.fwdarw.3)-.beta.-D-glucans The invention stabilizes single helix conformation (1.fwdarw.3)-.beta.-D-glucans by intramolecular crosslinking and provides (1.fwdarw.3)-.beta.-D-glucans... |
| US-5,574,022 |
Method of attenuating physical damage to the spinal cord A method is disclosed for attenuation of nervous system damage after injury which comprises administering therapeutic amounts of PREG, PREG-S, or esters of PREG... |
| US-5,574,021 |
Methods of treatment using 2',3'-dideoxy-2',2'-difluoronucleosides 2',3'-Dideoxy-2',2'-difluoronucleosides are useful for treating susceptible neoplasms and viral infections in mammals. |
| US-5,574,020 |
Tilmicosin formulation An aqueous, injectable, sustained release tilmicosin formulation comprises 250-350 mg/ml of tilmicosin and 250 mg/ml of propylene glycol, and has a pH adjusted... |
| US-5,574,019 |
Method of perfusing a primate The present invention relates to the field of compositions of matter, disclosing compositions of matter which as aqueous solutions, may be used to perfuse a... |
| US-5,574,018 |
Conjugates of vitamin B12 and proteins Therapeutically useful proteins are conjugated to vitamin B.sub.12 by covalent binding at the primary hydroxyl site of the ribose moiety. The resulting... |
| US-5,574,017 |
Antibacterial agents The present invention provides methods and pharmaceutical preparations for inhibiting the growth of bacterial microorganisms. |
| US-5,574,016 |
Peptide compound and a process for the preparation thereof The present invention concerns glycoprotein IIa/IIIb antagonists and platelet aggregation inhibitors of the formula (I): ##STR1## wherein R.sup.1 is aryl... |
| US-5,574,015 |
Isosteric antiherpes peptide derivatives Disclosed herein are peptide derivatives of the formula A-B-D-CH.sub.2 CH{CH.sub.2 C(O)R.sup.1 }C(O)-NHCH{CR.sup.2 (R.sup.3)COOH}C(O)-E wherein A is a terminal... |
| US-5,574,014 |
Inhibitors of trypsin-like enzymes Pharmaceutical compositions comprising compounds of the formula: ##STR1## in which X=H or is an N-protecting group; Y is Phe-Pro; Q1 and Q2 taken together... |
| US-5,574,013 |
N-substituted cycloalkyl and polycycloalkyl alpha-substituted Trp
derivatives Novel peptoids of .alpha.-substituted Trp derivatives useful as agents in the treatment of obesity, hypersecretion of gastric acid in the gut, gastrin-dependent... |
| US-5,574,012 |
Analogs of hirudin having anti-platelet activity This invention relates to peptide derivatives which are useful anticoagulant agents. |
| US-5,574,011 |
Compositions and methods for the treatment of male-pattern baldness The present invention provides methods and compositions of LHRH analogs for the treatment of male-pattern baldness. Male-pattern baldness is treated by the... |
| US-5,574,010 |
Treatment of pancreatic tumors with peptide YY and analogs thereof A method of inhibiting proliferation of pancreatic tumors. The method involves contacting the pancreatic tumor with an effective amount of peptide YY or an... |
| US-5,574,009 |
Method of stimulating myelination of cells The present invention provides methods for treating mammalian diseases and conditions characterized by myelin destruction. The present invention provides methods... |
| US-5,574,008 |
Biologically active fragments of glucagon-like insulinotropic peptide N-terminal truncated forms of glucagon like insulinotropic peptide (GLP-1) and analogs thereof are provided. The claimed polypeptides promote glucose uptake by... |
| US-5,574,007 |
Polypeptide capable of interacting with thrombin Disclosed is a substantially pure polypeptide having a specific amino acid sequence containing (a) an amino acid residue selected from the group consisting of... |
| US-5,574,006 |
Nasally administrable peptide compositions on hydroxyapatite carriers A physiologically active peptide composition having a physiologically active peptide dispersed homogeneously in and adsorbed homogeneously onto a unique carrier.... |
| US-5,574,005 |
Process for producing detergent agglomerates from high active surfactant
pastes having non-linear viscoelastic... A process for preparing detergent agglomerates for a detergent composition is provided. The process comprises the steps of: (a) providing a non-linear... |
| US-5,574,004 |
Carbonate built non-bleaching laundry detergent composition containing a
polymeric polycarboxylate and a zinc salt A non-bleaching laundry detergent composition, wherein the solids content comprises an active surfactant, at least about 70 wt. % of a water soluble alkaline... |
| US-5,574,003 |
Detergent compositions inhibiting dye transfer in washing A dye transfer inhibiting compositions are disclosed, comprising: A. an iron catalyst selected from a) iron porphin and water-soluble or water-dispersable derivatives... |
| US-5,574,002 |
Cleaning agent composition A cleaning agent composition is disclosed which is excellent in removing ability of the soldering flux, wax and machine oil, easy in waste water disposal, and... |
| US-5,574,001 |
Ceramic superconducting lead resistant to breakage A superconductive lead assembly for a superconductive device (e.g., magnet) cooled by a cryocooler coldhead having first and second stages. A first ceramic... |
| US-5,574,000 |
Cyclohexenone oxime ethers, their preparation and their use as herbicides Cyclohexenone oxime ethers of the general formula I ##STR1## where R.sup.1 is C.sub.1 -C.sub.6 -alkyl, A is substituted or unsubstituted C.sub.4 -alkylene... |
| US-5,573,999 |
.beta.-substituted cinnamic acid derivative .beta.-Substituted cinnamic acid derivatives of the formula 1, ##STR1## where R.sup.1 is alkyl, chlorine or bromine, --X-- is --O--, --S--, ##STR2## m... |
| US-5,573,998 |
Aqueous dispersions of sulfonediamide Herbicides such as amidosulfuron Herbicidal active substances from the sulfonediamide sulfonylurea series (e.g. amidosulfuron) were hitherto mainly formulated as WPs or WGs. The invention... |
| US-5,573,997 |
Herbicidal composition consisting essentially of acetic acid and citric
acid An aqueous herbicidal composition consisting essentially of about 1-5 wt. % acetic acid and 0.25 to 2.5 wt. % citric acid in a ratio of acetic:citric of about... |
Copyright 2008−2012 Patents.com
